Amrutanjan declares Re.1 interim dividend; Q2 profit up 18%

Corporate Actions View source PDF Explain this filing

AMRUTANJAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.7%Reaction day

₹701.90

prior close

₹711.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%+4.0% vs market

Pharmaceuticals peers, median of 157sector-0.2%+4.0% vs sector

On the reaction day the stock moved 4.0 pts more than Nifty Microcap 250 and 4.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+3.7

10m

+2.8

15m

+3.5

30m

+3.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.7-0.3+4.0-0.2+4.0

Next day

+1.3+0.7+0.7+0.5+0.8

+1.3+0.6+0.7+0.6+0.8

+3.0+0.5+2.5+0.3+2.7

+1.2+1.1+0.1+0.2+1.0

+0.3+0.3+0.0-0.6+0.9

-0.3-0.2-0.0-1.1+0.8

15d

-4.1-2.2-1.9-2.0-2.2

-7.5-4.9-2.6-2.9-4.7

-13.1-7.5-5.6-5.8-7.2

-7.5-4.8-2.7-6.4-1.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board declared first interim dividend of Re.1 per share for FY26. Q2 revenue rose to Rs 11,770 lakhs (up 7 percent) from Rs 10,991 lakhs a year ago. Q2 profit after tax grew 18 percent to Rs 1,396 lakhs from Rs 1,180 lakhs. For the half year, revenue was Rs 21,175 lakhs (up 9 percent) and PAT was Rs 2,227 lakhs (up 36 percent). OTC products remained the biggest segment with Rs 8,002 lakhs in Q2 revenue. Limited review report by auditor is unmodified.

Likely market impact

Interim dividend plus strong H1 profit growth signals healthy cash generation, positive for shareholders and likely supportive of the stock.